Uher, D., Yoon, L., Garber, C. E., & Montes, J. (2023). How is Physical Activity Measured in Spinal Muscular Atrophy and Duchenne Muscular Dystrophy? Journal of Neuromuscular Diseases, 10(5), 897–914. https://doi.org/10.3233/jnd-230033

Maloney, B., Park, S., Sowizral, M., Brackett, I., Moslehi, R., Chung, W. K., Gruber, D., Brower, A., Lloyd-Puryear, M., Caggana, M., & Tavakoli, N. P. (2023). Factors influencing creatine kinase-MM concentrations in newborns and implications for newborn screening for Duchenne muscular dystrophy. Clinical Biochemistry, 118, 110614. https://doi.org/10.1016/j.clinbiochem.2023.110614

Tavakoli, N. P., Gruber, D., Armstrong, N., Chung, W. K., Maloney, B., Park, S., Wynn, J., Koval‐Burt, C., Verdade, L., Tegay, D. H., Cohen, L. L., Shapiro, N., Kennedy, A., Noritz, G., Ciafaloni, E., Weinberger, B., Ellington, M., Schleien, C., … Spinazzola, R. (2023). Newborn screening for Duchenne muscular dystrophy: A two‐year pilot study. Annals of Clinical and Translational Neurology, 10(8), 1383–1396. Portico. https://doi.org/10.1002/acn3.51829

Xie, Z., Sun, C., Liu, C., Xie, Z., Wei, L., Yu, J., Ling, C., Guo, X., Liu, Y., Yu, M., Leng, Y., Meng, L., Sun, Y., Deng, J., Leal, S. M., Schrauwen, I., Wang, Z., & Yuan, Y. (2022). Clinical, muscle imaging, and genetic characteristics of dystrophinopathies with deep-intronic DMD variants. Journal of Neurology, 270(2), 925–937. https://doi.org/10.1007/s00415-022-11432-0